CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

James Pekarsky Joins Gelteq as Chief Financial Officer

Life Sciences Review Life Sciences Review | Tuesday, July 27, 2021
Tweet

Gelteq appoints James Pekarsky as CFO.


FREMONT, CA: Gelteq Pty Ltd, a global leader in ingestible gel technology for healthcare, nutrition, and sports, appoints James Pekarsky as the Chief Financial Officer, as the company accelerates its global launch, including its first significant entry into the United States market.


Pekarsky offers over 30 years of finance and executive experience from biotechnology and technology companies to Gelteq. This includes 15 years as CEO and CFO of publicly traded companies, five years as general manager of large US-based companies operating in Europe, and ten years as a founder and CEO of start-up companies in Silicon Valley, where he led several financings, initial public offerings, acquisitions, and exits.


Pekarsky formerly co-founded and ran BioPharmX, a NYSE-listed business focused on new pharmaceutical delivery technologies, where he led several financings and the firm's initial public offering. He has since worked as an executive consultant for private firms in the medical and high-tech sectors, advising on all aspects of finance and operations, including fundraising, mergers and acquisitions, business development, and corporate governance.


“We welcome Jim’s extensive financial knowledge and operational experience, particularly his success with developing novel pharma delivery systems,” states Simon Szewach, Gelteq co-founder and executive chairman. “His proven capabilities and knowhow greatly complement our fast-track for growth and our expanding team of industry pioneers. 


We expect Jim to play an essential role as we continue to ramp our sales and marketing, manufacturing and licensing programs on a global scale, as well as pursue opportunities in the capital markets to accelerate this growth.”


Pekarsky served as CFO of several successful semiconductor companies before co-founding BioPharmX, including Wavesat (acquired by Cavium Networks/Marvell), SiliconBlue Technologies (developed by Lattice), Mosys (a Nasdaq-listed company), AccelChip (acquired by Xilinx), and Virage Logic Corporation (acquired by Synopsis). He also oversaw Virage's Nasdaq initial public offering.


“I see tremendous market opportunities and multiple ways for Gelteq to capitalize on its extensive IP portfolio and growing number of international patents that support its innovative gel delivery system,” comments Pekarsky. “The sports, health and wellness, and pharma partnerships the company has formed are impressive and support its commercial rollout. Im looking forward to supporting the company’s continued growth and international expansion.”


Pekarsky earned a bachelor's degree in accounting from the Indiana University of Pennsylvania and a master's degree in business administration from Golden Gate University in San Francisco.


Weekly Brief

loading
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/james-pekarsky-joins-gelteq-as-chief-financial-officer-nwid-467.html